Therefore, HMGB1 affects progression and severity of CAD and it could be involved in major adverse cardiac events (MACE) in diabetic patients after acute myocardial infarction; however, further studies are needed to verify this hypothesis. Here, HMGB1 is linked to coronary artery disorder.